Atlas Genetics
Innovate UK Awards Atlas Genetics £2M Grant for Rapid Diagnostic Platform
The company said it will use the funds to expand its menu of STI tests and launch its io rapid diagnostic platform into UK sexual health clinics.
Atlas Genetics Raises $35M in Series D Fundraising
The funding comes from a syndicate which includes all Series C investors and one new investor, Chinese assay developer Wondfo Biotech.
Atlas Genetics Garners CE Mark for Chlamydia Test, Point-of-Care MDx Platform
Evaluations of the test, which takes about 30 minutes to perform, demonstrated performance equivalent to a gold standard lab-based test.
UK's NIHR Grants £1.5M to Develop Infectious Disease and Resistance POC Testing
The grant will go to Atlas Genetics and St. George's University of London to develop and validate infectious disease and antibiotic resistance testing.